Nadim Ahmed is President and Chief Executive Officer of Cullinan Therapeutics, Inc. (CGEM). The company reported total compensation of $5,100,006 for fiscal year 2025.
| Salary | $698,476 |
|---|---|
| Bonus | $0 |
| Stock awards | $1,697,400 |
| Option awards | $2,234,340 |
| Non-equity incentive plan | $419,086 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $50,704 |
| Total | $5,100,006 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Cullinan Therapeutics, Inc. filed April 28, 2026, accession 0001193125-26-183465.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President and Chief Executive Officer | $698,476 | $0 | $1,697,400 | $2,234,340 | $419,086 | $0 | $50,704 | $5,100,006 |
| FY2024 | President and Chief Executive Officer | $674,856 | $0 | $2,806,400 | $3,704,160 | $455,528 | $0 | $43,422 | $7,684,366 |
Totals as disclosed in each year's own compensation disclosure for Cullinan Therapeutics, Inc..
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Nadim Ahmed this page | President and Chief Executive Officer | $5,100,006 |
| Jeffrey Jones | Chief Medical Officer | $2,221,578 |
| Mary Kay Fenton | Chief Financial Officer | $2,078,837 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Cullinan Therapeutics, Inc. compensation brief.
Nadim Ahmed's compensation sits inside Cullinan Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.